Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

During the Trading Day
4.09 +0.29 / +7.63%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
4.09 +0.0008 / +0.02%
Volume: 2.6K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 4
Quarter 1
Quarter 2
Quarter 3
Revenue and IncomeNet Revenues0.
Depreciation And Amortization184.0K178.0K174.0K175.0K
Operating ExpensesGross Income-184.0K-178.0K-174.0K-175.0K
General Expenses3.7M5.3M5.6M5.7M
Research And Development1.6M2.3M2.5M2.4M
Total Operating Expenses3.8M5.5M5.8M5.9M
Non-Operating ExpensesOperating Income-3.8M-5.5M-5.8M-5.9M
Extraordinary Credit--
Extraordinary Charge-4.5M-10.3M-4.7M0.00
Interest Expense On Debt34.0K34.0K32.0K32.0K
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.4M-15.8M-10.4M-2.3M
Net Income-8.4M-15.8M-10.4M-2.3M
Shares To Calculate EPSShares To Calculate EPS23.5M24.9M26.5M27.0M
Shares To Calculate EPS Diluted23.5M24.9M26.5M27.0M
Earnings Per ShareEPS-$0.36-$2.56-$0.39-$0.09
EPS Diluted-$0.36-$0.64-$0.39-$0.09